Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
38.97
-0.52 (-1.32%)
Sep 3, 2026, 2:53 PM EDT - Market open
Immunovant Employees
Immunovant had 315 employees as of March 31, 2026. The number of employees decreased by 47 or -12.98% compared to the previous year.
Employees
315
Change (1Y)
-47
Growth (1Y)
-12.98%
Revenue / Employee
n/a
Profits / Employee
-$1,708,625
Market Cap
8.05B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 315 | -47 | -12.98% |
| Mar 31, 2025 | 362 | 155 | 74.88% |
| Mar 31, 2024 | 207 | 43 | 26.22% |
| Mar 31, 2023 | 164 | 40 | 32.26% |
| Mar 31, 2022 | 124 | 56 | 82.35% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| ImmunityBio | 691 |
| Crinetics Pharmaceuticals | 594 |
| Vaxcyte | 507 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
| Scholar Rock Holding | 289 |
| Kymera Therapeutics | 273 |
IMVT News
- 24 days ago - Immunovant price target raised to $45 from $43 at BofA - TheFly
- 4 weeks ago - Immunovant Slides: Corporate presentation - Filings
- 4 weeks ago - Immunovant reports Q2 EPS (75c), consensus (61c) - TheFly
- 4 weeks ago - Immunovant Earnings Call Transcript: Q1 2027 - Transcripts
- 4 weeks ago - Immunovant Earnings release: Q1 2027 - Filings
- 4 weeks ago - Immunovant Quarterly report: Q1 2027 - Filings
- 4 weeks ago - Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026 - GlobeNewsWire
- 4 weeks ago - Immunovant price target raised to $50 from $47 at JPMorgan - TheFly